Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

May 19, 2025 09:40 ET | Source: Nika Pharmaceuticals, Inc.

Nika Pharmaceuticals, Inc. (NIKA) Markets Analysis and €8.5 Billion Projected Revenue

Nika Pharmaceuticals, Inc. (OTCQB: NIKA) projects €8.5 Billion revenue from its distribution agreements for Nigeria, Ukraine, UAE, Iraq, Syria, and Jordan.
April 11, 2025 11:35 ET | Source: Nika Pharmaceuticals, Inc.

Nika Pharmaceuticals, Inc. (NIKA) Latest Developments

Nika Pharmaceuticals, Inc. (OTCQB: NIKA)'s report on the therapeutic effect of ITV-1 on AIDS, Cancer, Hepatitis volunteers and Nika Europe factory progress
June 03, 2024 10:35 ET | Source: Nika Pharmaceuticals, Inc.

Nika Pharmaceuticals, Inc. (NIKA) Presents Its Business Strategy

Nika Pharmaceuticals, Inc. (NIKA) introduces its business strategy that should generate a net profit of more than 1 billion USD by the end of 2025.
May 10, 2024 13:41 ET | Source: Nika Pharmaceuticals, Inc.

Nika Pharmaceuticals, Inc. (NIKA) Acquires a Two Million USD Production Building

Nika Pharmaceuticals, Inc. (NIKA) acquired production building and land valued at $2,045,209 and signed a supply agreement for vial production line.
May 10, 2024 12:55 ET | Source: Nika Pharmaceuticals, Inc.

Nika Pharmaceuticals, Inc. (Nika) Acquires a Two Million USD Production Building

Nika Pharmaceuticals, Inc. (NIKA) acquired production building and land valued at $2,045,209 and signed a supply agreement for vial production line.